Diabetes. Health Care Disparities: Medical Evidence. A Constellation of Complications. Every 24 hours.

Similar documents
1,2,3 1. Diabetes in the Latino Population: A Case-based Approach to Optimal Management. Why Are We Concerned about Diabetes Among Latinos?

National Diabetes Fact Sheet, 2011

Why do we care? 20.8 million people. 70% of people with diabetes will die of cardiovascular disease. What is Diabetes?

National Diabetes Fact Sheet, 2007

Eugene Barrett M.D., Ph.D. University of Virginia 6/18/2007. Diagnosis and what is it Glucose Tolerance Categories FPG

American Academy of Insurance Medicine

Helpful Hints for Taking Care of Your Diabetes. Farahnaz Joarder, MD and Don Kain, MA, RD,CDE Harold Schnitzer Diabetes Health Center

Diabetes: Staying Two Steps Ahead. The prevalence of diabetes is increasing. What causes Type 2 diabetes?

GED 2002 Teachers Handbook of Lesson Plans

MANAGEMENT OF DIABETES IN MINORITIES: A MATTER OF URGENCY

Kidney and heart: dangerous liaisons. Luis M. RUILOPE (Madrid, Spain)

Diabetes Day for Primary Care Clinicians Advances in Diabetes Care

Diabetes in the Latino/Hispanic Population The case for education and outreach

An Epidemiological Perspective on Type 2 Diabetes Among Adult Men

A Summary Report: 2003

Why Do We Care About Prediabetes?

Statistical Fact Sheet Populations

Diabetes - Deaths African Americans and Latinos are more likely to die from diabetes than other Contra Costa residents.

2017 USRDS ANNUAL DATA REPORT KIDNEY DISEASE IN THE UNITED STATES S611

The Metabolic Syndrome: Is It A Valid Concept? YES

Diabetes 101: A Brief Overview of Diabetes and the American Diabetes Association

Why is Earlier and More Aggressive Treatment of T2 Diabetes Better?

Diabetes Mellitus: A Cardiovascular Disease

Healthy Montgomery Obesity Work Group Montgomery County Obesity Profile July 19, 2012

Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone

This slide set provides an overview of the impact of type 1 and type 2 diabetes mellitus in the United States, focusing on epidemiology, costs both

Diabetes Overview. How Food is Digested

Macrovascular Residual Risk. What risk remains after LDL-C management and intensive therapy?

Objectives 10/11/2013. Diabetes- The Real Cost of Sugar. Diabetes 101: What is Diabetes. By Ruth Nekonchuk RD CDE LMNT

Shaping our future: a call to action to tackle the diabetes epidemic and reduce its economic impact

Diabetes. For Institute for Healthy Aging at Keiro. Take Time To Care

Diabetes Complications Recognition and Treatment

Diabetes Mellitus Type 2 Evidence-Based Drivers

Diabetes: What is the scope of the problem?

TAHFA-South Texas HFMA Fall Symposium. Tuesday, October 17, from 10:45 AM 11:35 AM.

Preventive Cardiology Scientific evidence

Clinical Practice Guidelines for Diabetes Management

DIABETES MEASURES GROUP OVERVIEW

Before the Pre. PREDIABETES Diagnosis, Management, Treatment. A few thoughts on diabetes.

Tobacco Use, Diabetes and other Chronic Diseases: Take Action for Cessation

A: Epidemiology update. Evidence that LDL-C and CRP identify different high-risk groups

Adult Diabetes Clinician Guide NOVEMBER 2017

Reducing Acute and Chronic Events from Diabetes

A factorial randomized trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

Welcome and Introduction

Reporting by Racial Subgroups Hawai i. Jill Miyamura, PhD Hawaii Health Information Corporation

Myths, Heart Disease and the Latino Population. Maria T. Vivaldi MD MGH Women s Heart Health Program. Hispanics constitute 16.3 % of US population!

Chronic Kidney Disease

ELIMINATING HEALTH DISPARITIES IN AN URBAN AREA. VIRGINIA A. CAINE, M.D., DIRECTOR MARION COUNTY HEALTH DEPARTMENT INDIANAPOLIS, INDIANA May 1, 2002

Diabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable?

Diabetes 101: A Brief Overview of Diabetes and the American Diabetes Association

Cedars Sinai Diabetes. Michael A. Weber

Wayne Gravois, MD August 6, 2017

ASN s Legislative Priorities for 2010

Diabetic Kidney Disease Tripti Singh MD Department of Nephrology University of Wisconsin

DIABETES AND THE AT-RISK LOWER LIMB:

Indiana Medicaid Drug Utilization Review Board Newsletter

What s the Goal? Individualizing Glycemic Targets. Matthew Freeby M.D. December 3 rd, 2016

Guiding Principles. for Diabetes Care: For Health Care. Providers

HEALTH PROMOTION AND CHRONIC DISEASE PREVENTION PROGRAM OREGON STATE OF THE HEART AND STROKE REPORT 2001 PREPARED BY.

Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES

Diabetes and the Heart

Oral Hypoglycemics and Risk of Adverse Cardiac Events: A Summary of the Controversy

Use of Real-World Data for Population Surveillance and Monitoring. Kasia Lipska, MD Yale School of Medicine November 17 th, 2018.

Type 2 Diabetes in Adolescents

MICHIGAN DIABETES. ACTION PLAN Working Together to Prevent and Control Diabetes GOALS FOR Diabetes Partners in Action Coalition

Type 2 Diabetes Prevention. By: Montano Labadia And Mary Rose Cairel

Creating Policy to Promote and Support Individual Change. Ann Albright, PhD, RD

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology

CV Risk Management in Diabetes Mellitus

America s Foremost Insurance Brokerage Network Diabetes Guidelines

Approximately one third of the 15.7 million Americans who are estimated to have diabetes

Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015

Diabetes Mellitus: Evaluation and Care Management

Diabetes: A Costly Problem

Diabetes Mellitus: Implications of New Clinical Trials and New Medications

Page 0 of 20. Health Profiles. Diabetes Montgomery County, OH. Public Health - Dayton & Montgomery County Epidemiology Section

Practical Diabetes. Nic Crook. (and don t use so many charts) Kuirau Specialists 1239 Ranolf Street Rotorua. Rotorua Hospital Private Bag 3023 Rotorua

Diabetic Kidney Disease Tripti Singh MD Department of Nephrology University of Wisconsin

Diabetes Care Begins With Diabetes Prevention

Finding the sweet spot: Individualized targets for older adults with Type 2 DM

Lessons from conducting research in an American Indian community: The Pima Indians of Arizona

Addressing Addressing Challenges in Type 2 Challenges in Type 2 Diabetes Diabetes Speaker:

Pre Diabetes Screening in Primary Care

IMPROVED DIAGNOSIS OF TYPE 2 DIABETES AND TAILORING MEDICATIONS

The Diabetes Link to Heart Disease

Donna Tomky, MSN, C-ANP, CDE, FAADE Albuquerque, New Mexico

10/8/13. the diabetes epidemic: strategies for saving sight. financial disclo$ure. unlabeled-investigative use disclosure

Diabetes Mellitus. Medical Management and Latest Developments Dr Ahmad Abou-Saleh

LIRAGLUTIDE VS EXENATIDE IN COMBINATION WITH METFORMIN AND/OR SULFONYLUREA THERAPY IN TYPE 2 DIABETES MELLITUS THERAPY IN BULGARIA. A MODELLING STUDY.

Roadmap. Diabetes and the Metabolic Syndrome in the Asian Population. Asian. subgroups 8.9. in U.S. (% of total

He has attended diabetes education classes with Dorothy. He eats less, and the couple walks together every day.

Addressing Racial and Ethnic Disparities in Diabetes Care. Development and Support. Accreditation Information

United States General Accounting Office. Testimony Before the Select Committee on Aging, House of Representatives

Diabetic Retinopathy and Neuropathy: 2018 Clinical Practice Guidelines

Standards of Medical Care In Diabetes

Living Well with Diabetes

Hanyang University Guri Hospital Chang Beom Lee

Diabetic Nephropathy. Objectives:

Type 1 diabetes, although the most common

Transcription:

Health Care Disparities: Medical Evidence Diabetes Effects 2.8 Million People in US 7% of the US Population Sixth Leading Cause of Death Kenneth J. Steier, DO, MBA, MPH, MHA, MGH Dean of Clinical Education TouroCOM Every 24 hours. 3,6 new cases are diagnosed 58 people die of diabetes-related complications 225 people have a diabetes-related amputation 12 people with diabetes progress to end-stage renal disease 55 people with diabetes become blind Peripheral Vascular Disease Gastropathy A Constellation of Complications Dyslipidemia Erectile Dysfunction Renal Disease Diabetes Cardiovascular Disease Peripheral Neuropathy Retinopathy/ Macular Edema Autonomic Neuropathy Hypertension Diabetes Care in the U.S. Improvements Needed Goal Percent at Goal A1C < 7. 43% (18% at > 9.5) LDL < 1 11% (58% at > 13) BP < 14/9 (ADA goal is 13/8) 66% Dilated Eye Exam 63% Foot Exam 55% Projected Increase (%) Projected Increase in the US Population with Diagnosed Diabetes by 22 by Ethnicity NHANES III and Behavioral Risk Factors Surveillance Study Adapted from American Diabetes Association. Diabetes Care. 23;26:917-932 X-1

Age-adjusted prevalence (%) 1 8 6 4 2 Prevalence of Type 2 Diabetes Physician-diagnosed diabetes Non-Latino African Mexican Non-Latino African Mexican American American American American Harris MI et al. Diabetes Care. 1998;21:518-524. Previously undiagnosed diabetes Trends in Diabetes Prevalence (199-1998) Age (years) Ethnicity 8 5 7 4 6 5 3 4 3 2 2 1 1 3-39 4-49 5-59 Non-Latino African Mexican American American Prevalence of type 2 diabetes is 2-3 times higher in Latinos than Caucasians Highly correlated with prevalence of obesity (r =.64, P <.1) American Diabetes Association. Facts and Figures. Mokdad et al. Diabetes Care. 2;23:1278. Complications The Leading Cause of: Adult Blindness Kidney Failure Non-traumatic amputations Major cause of: Heart Disease Patients (%) Prevalence of Complications in Type 2 Diabetes 4 2 Prevalence of Retinopathy in Type 2 Diabetes 4 59 years 6 years (per million/population) 3 2 1 New Cases of End-Stage Renal Disease Age Range of Amputations per 1, DM patients Caucasian African-American Mexican-American 2 16 12 8 4 Stroke Klein et al. In: Harris et al, eds. Diabetes in America, 2nd ed. 1995. Reiber et al. In: Harris et al, eds. Diabetes in America, 2nd ed. 1995. USRDS. Am J Kidney Dis. 1994;24:879. What Aren t Patients Achieving Blood Glucose Goals? Physicians not setting appropriate glycemic targets Type 2 DM is progressive Type of medication used Insulin therapy used only as a threat Monitoring Parameters Every visit BP and foot exam HgbA1C every three to six months Annual eye exam, lipid level, microalbumin X-2

Principles of Treatment Define target goal Education is essential Monitoring glycemic control Lifestyle modification Stepwise and combination drug therapy Estimated Costs Direct: $132 billion annually (HHS) Indirect: Disability and Premature Death Pre-diabetes Approximately 41 million more Americans aged 4-74 HHS Diabetes Prevention Program of 3 pre-diabetics found that diet and exercise, with moderate weight loss, can decrease incidence of developing Diabetes by nearly 6 per cent At-risk Groups African-American Hispanic American Indian Alaska Native Three Major Types Type 1 5 to 1% IDDM Type 2.9-95%.NIDDM disparities Gestational Diabetes.disparities African-Americans 2.4 times as likely to have diabetes as whites Maximal incidence women age 65-75 Diabetic eye disease 19% more common in African-American men than white men Lower extremity amputation much more common in AA. X-3

Hispanics As of 22, two million Hispanic adults, about 8.2% of the Hispanic population had diabetes Hispanics 1.5 times more likely to have diabetes than whites Mexican-Americans, the largest group, more than twice as likely as whites In 22, death rate from Diabetes 6% higher or Hispanics than whites American Indians/Alaska Natives 2.3 times as likely as whites to have diabetes As of 24, 14.9 per cent of this population in the Indian Health Service had a diagnosis of diabetes Most common among American Indians in the southeastern US and Arizona (27.8%) Asian American and Pacific Islander Diabetes is the fifth leading cause of death In Hawaii, native Hawaiians more than 5.7 times as likely as whites (in Hawaii) to have diabetes Overall, this population 2. times more likely to have diabetes than whites. African-Americans 2.4 times more likely to be diagnosed with Diabetes In 21, 2.3 times more likely to start treatment for end-stage renal disease from diabetes In 22, 1.5 times more likely to be hospitalized In 22, 3% more likely to need lower extremity amputation In 22, 2.2 times more likely to due from diabetes Hispanic Americans Asians and Pacific Islanders In Hawaii, Native Hawaiians have more than twice the rate of diabetes Asians 2% less likely than whites to die from diabetes Native Hawaiians in Hawaii more than 5.7 times to die from diabetes Filipinos living in Hawaii have more than 3 times the death rate as whites living in Hawaii. Insulin Sensitivity Index (µmol L -1 m -2 min -1 pmol -1 L -1 ) Insulin Sensitivity in Healthy Subjects in Various Ethnic Groups * N=34 N=9 N=18 N=16 *P =.23 vs. Caucasians. Data are geometric means. Adapted from: Chiu KC, et al. Diabetes Care. 2;23(9):1353-1358. * * X-4

Prevalence (% of adults) Prevalence of the Insulin Resistance Syndrome in the US Population Progressive Nature of Type 2 Diabetes IGT Endogenous Insulin Insulin Resistance Postprandial Blood Glucose Diabetes Normal Normal Blood Glucose *Age adjusted 2 years of age Ford ES et al. JAMA. 22;287:356-359 Years Avg Dx 9-12 yrs* UKPDS: Glucose Control Study Results Intensive Blood- Glucose Control Change in risk P value Any diabetes-related endpoint 12%.29 Diabetes-related deaths 1% NS Myocardial infarction 16%.52 Microvascular disease 25%.99 Stroke 14% NS Effect of Each 1% Rise in A1C on Risk of Developing Complications 1-Year follow-up in older-onset patients Incidence of retinopathy Progression of retinopathy Progression to PDR Visual loss Proteinuria Amputation Ischemic heart death Adapted from UKPDS Group. Lancet. 1998; 352:837-853. Klein. Diabetes Care 18:258-268, 1995.5 1 1.5 2 2.5 Risk Ratio and 95% CI Rate of Initiation of Treatment for ESRD per 1, Diabetics Age-adjusted Rate of hospitalization per 1, diabetics African Americans Men 54.3 Women 356.2 Men 222.1 Women 176.4 African American 72.6 49.1 Ratio 2.3 Men Ratio 2. Women Ratio 1.5 X-5

Age-adjusted rate for lower extremity amputation per 1, Diabetic Patients African-Americans 5.3 s 4.1 Age-adjusted Diabetes Death Rates per 1, African Americans 49.5 s 22.2 Ratio 1.3 Ratio 2.2 Age-adjusted percentage of persons over 2 with a high cholesterol Age-adjusted ratio of person 18 and over who had received a flu shot in 21 African American Men 12.4 Women 17.7 Men 16.5 Women 18.1 African American 47.2 6.1 Ratio.8 Ratio.8 Rate of Initiation of treatment for ESRD in Hispanic Diabetics per 1, Diabetic Population Hispanic/Latino Men 39.4 Women 266.1 Men 222.1 Women 176.4 Age-adjusted Death Rates per 1, Hispanic 35.6 22.2 Ratio 1.5 women Ratio 1.4 men Ratio 1.6 X-6

Impact of Therapies on A1C Levels Therapy A1C Reduction Diet and Exercise.5-2.% Sulfonylureas and Glitinides 1. - 2.% Metformin 1. - 2.% α-glycosidase Inhibitors.5-1. % Thiazolidinedione.5-1.% Insulin >5.% Nathan, D. Oct 22. N Engl J Med, Vol. 347, No.17 No Difference In Complications When Good Control Is Achieved San Luis Valley Study Caucasian and Latino (n=279) - Similar glucose control in both study groups - Similar severity of retinopathy, nephropathy and diabetic neuropathy Hamman RF et al. Diabetes. 1989; 38;1231. Hamman RF et al. Diabetes Care. 1991;14 (suppl 3):655. Whose Responsible? Health Care System? Federal Government? State Government? Physicians and other health care? providers The Patients? Genetics? Also Multifactorial Government Private Industry Medical Societies Solutions Individual Physicians Medical School Education Residency Training References www.cdc.gov/diabetes/pubs/ www.omhrc.gov. www.his.gov/medicalprograms/diabete s/ http://www.os.dhhs.gov/specificpopulati ons/ http://www.qualitytools.ahrq.gov/dispariti esreport/25/ Additional References Institute of Medicine, Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Washington DC: National Academies Press;23. Brown AF, Gross AG, et al. Income-related differences in the use of evidence-based therapies in older persons with diabetes mellitus in for-profit managaed care. J AM Geriatr Soc. 23 May:51(5) 665.7 X-7

The END Thank you. X-8